MM LAB Software Matches Oncology Patients to Treatments
The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs.
MolecularMatch, a personalized cancer treatment company launched its MM LAB software, which is available through an online portal. The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs, in real-time. After test results are matched to treatments in MM LAB, the options are curated by the client laboratory's staff and included in the reports sent back to physicians and patients. The solution works using molecular science / artificial intelligence based algorithms.
Read the
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025